Delving into Molecular Pathways: Analyzing the Mechanisms of Action of Monoclonal Antibodies Integrated in IMGT/mAb-DB for Myasthenia Gravis
Background: Myasthenia Gravis (MG) is a rare autoimmune disease presenting with auto-antibodies that affect the neuromuscular junction. In addition to symptomatic treatment options, novel therapeutics include monoclonal antibodies (mAbs). IMGT<sup>®</sup>, the international ImMunoGeneTic...
Main Authors: | Rebecca Golfinopoulou, Véronique Giudicelli, Taciana Manso, Sofia Kossida |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/12/1756 |
Similar Items
-
Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
by: Taciana Manso, et al.
Published: (2023-05-01) -
IMGT/StatClonotype for pairwise evaluation and visualization of NGS IG and TR IMGT clonotype (AA) diversity or expression from IMGT/HighV-QUEST
by: Safa Aouinti, et al.
Published: (2016-09-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
IMGT/mAb-KG: the knowledge graph for therapeutic monoclonal antibodies
by: Gaoussou Sanou, et al.
Published: (2024-06-01) -
IMGT-ONTOLOGY 2012
by: Véronique eGiudicelli, et al.
Published: (2012-05-01)